Robert C Merton - Net Worth and Insider Trading
Robert C Merton Net Worth
The estimated net worth of Robert C Merton is at least $224 dollars as of 2024-11-13. Robert C Merton is the Director of Fresh Tracks Therapeutics Inc and owns about 303 shares of Fresh Tracks Therapeutics Inc (FRTX) stock worth over $224. Details can be seen in Robert C Merton's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Robert C Merton has not made any transactions after 2017-11-10 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Robert C Merton
Robert C Merton Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Robert C Merton owns 1 companies in total, including Fresh Tracks Therapeutics Inc (FRTX) .
Click here to see the complete history of Robert C Merton’s form 4 insider trades.
Insider Ownership Summary of Robert C Merton
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| FRTX | Fresh Tracks Therapeutics Inc | 2017-11-10 | director |
Robert C Merton Latest Holdings Summary
Robert C Merton currently owns a total of 1 stock. Robert C Merton owns 303 shares of Fresh Tracks Therapeutics Inc (FRTX) as of November 10, 2017, with a value of $224.
Latest Holdings of Robert C Merton
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| FRTX | Fresh Tracks Therapeutics Inc | 2017-11-10 | 303 | 0.74 | 224 |
Holding Weightings of Robert C Merton
Robert C Merton Form 4 Trading Tracker
According to the SEC Form 4 filings, Robert C Merton has made a total of 0 transactions in Fresh Tracks Therapeutics Inc (FRTX) over the past 5 years. The most-recent trade in Fresh Tracks Therapeutics Inc is the acquisition of 272 shares on November 10, 2017, which cost Robert C Merton around $149,975.
Insider Trading History of Robert C Merton
- 1
Robert C Merton Trading Performance
GuruFocus tracks the stock performance after each of Robert C Merton's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Robert C Merton is -19.07%. GuruFocus also compares Robert C Merton's trading performance to market benchmark return within the same time period. The performance of stocks bought by Robert C Merton within 3 months outperforms 1 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Robert C Merton's insider trading performs compared to the benchmark.
Performance of Robert C Merton
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -1.44 | | | | | |
| Relative Return to S&P 500(%) | -2.57 | | | | | |
Robert C Merton Ownership Network
Ownership Network List of Robert C Merton
Ownership Network Relation of Robert C Merton
Robert C Merton Owned Company Details
What does Fresh Tracks Therapeutics Inc do?
Who are the key executives at Fresh Tracks Therapeutics Inc?
Robert C Merton is the director of Fresh Tracks Therapeutics Inc. Other key executives at Fresh Tracks Therapeutics Inc include Chief Medical Officer Monica E. Luchi , director & CHAIRMAN OF THE BOARD Reginald L Hardy , and General Counsel and CCO David R. Mcavoy .
Fresh Tracks Therapeutics Inc (FRTX) Insider Trades Summary
Over the past 18 months, Robert C Merton made no insider transaction in Fresh Tracks Therapeutics Inc (FRTX). Other recent insider transactions involving Fresh Tracks Therapeutics Inc (FRTX) include a net sale of 110 shares made by ,
In summary, during the past 3 months, insiders sold 0 shares of Fresh Tracks Therapeutics Inc (FRTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 110 shares of Fresh Tracks Therapeutics Inc (FRTX) were sold and 1,086,412 shares were bought by its insiders, resulting in a net purchase of 1,086,302 shares.
Fresh Tracks Therapeutics Inc (FRTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Fresh Tracks Therapeutics Inc Insider Transactions
Robert C Merton Mailing Address
Above is the net worth, insider trading, and ownership report for Robert C Merton. You might contact Robert C Merton via mailing address: 10390 Pacific Center Court, San Diego Ca 92121.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
